AIFF Firefly Neuroscience, Inc. logo

AIFF Firefly Neuroscience, Inc.

Technology
$1.75+2.34%ClosedMarket Cap: $27.3M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

PEG

P/B

3.36

P/S

17.20

EV/EBITDA

-2.76

DCF Value

$-0.13

FCF Yield

-28.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

52.0%

Operating Margin

-539.8%

Net Margin

-565.4%

ROE

-94.7%

ROA

-82.1%

ROIC

-101.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$485.0K$-2.0M$
Q4 null$412.0K$-2.5M$
FY null$1.1M$-19.9M$
Q3 null$388.0K$-2.6M$

Analyst Ratings

View All

Consensus

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
Lipschitz Gregorydirector, officer: Interim CEO
SellFri Mar 13
Lipschitz Gregorydirector, officer: Chief Executive Officer
SellThu Mar 12
DeCaprio Daviddirector, officer: President and COO
SellThu Mar 12
Vnook Stelladirector
SellThu Oct 30
POSNER BRIAN Mdirector
SellThu Oct 30

Company Info

Sector

Technology

Industry

Software - Application

Country

CA

Exchange

Beta

0.60

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Peers